Skip to main content
A-LevelBiologyGenetic technology9700/41 · Oct/Nov 2022 · Q413 Marks

Adenosine deaminase (ADA) deficiency is an immune system disorder caused by a recessive autosomal mutation. Severe combined immunodeficiency caused by a lack of ADA is called ADA-SCID.

  1. (a)Genetic engineering is used to make a recombinant human protein to treat people with ADA-SCID. Outline the principles of genetic engineering.[4]
  2. (b)In 2016 gene therapy to cure ADA-SCID was approved in Europe. The gene therapy involves three main steps. • Blood (haematopoietic) stem cells are taken from the bone marrow of the person with ADA-SCID. • The functional gene and its promoter are inserted into the blood stem cells. • A single infusion (injection) of the gene-corrected cells is given to the patient.
  3. (b)(i)Explain why a single infusion of gene-corrected stem cells is enough to cure the disease.[2]
  4. (b)(ii)Explain why a promoter has to be transferred as well as the desired gene.[2]
  5. (b)(iii)A modified retrovirus is used to insert the new gene into the DNA of the blood stem cells. State two ethical considerations of using a retrovirus for gene therapy.[2]
  6. (c)The gene therapy technique used to cure ADA-SCID is not suitable for treating the genetic disease called Huntington's disease. A newer technique called gene editing could potentially be used instead to cure Huntington's disease. Explain why gene editing is more suitable as a potential cure for Huntington's disease.[3]

Mark scheme

Marking points from the official mark scheme (Oct/Nov 2022). The mark or mark type is shown in brackets.

  1. [4] (a) any four from: 1 add DNA to give a new (named), characteristic / protein; 2 restriction, enzyme / endonuclease, to obtain, gene / allele / section of DNA or restriction, enzyme / endonuclease, to cut plasmid ; 3 combine gene with / insert gene into, vector / plasmid; 4 introduce, (recombinant) vector / plasmid, to, bacterium / (named host) cell ; 5 clone / multiply, (named, recombinant / GM) organism ; 6 AVP;
  2. [2] (b)(i) 1 stem cells, proliferate / divide / multiply / make new cells ; 2 (correct) gene is, inherited by / passed to / present in, new cells ;
  3. [2] (b)(ii) any two from: 1 to switch gene on / so gene is expressed / allow transcription; 2 at right time / all the time / in sufficient quantities ; 3 to allow binding of, RNA polymerase / transcription factors ;
  4. [2] (b)(iii) any two from: 1 retrovirus / new gene, could / must not, insert in wrong place / disrupt other genes ; 2 could / must not, cause cancer ; 3 could / must not, cause, infection / disease ; 4 could / must not, cause, immune / allergic, response ; 5 AVP;
  5. [3] (c) any three from: 1 HD is caused by a dominant allele ; 2 adding a 'normal' recessive allele would not work; 3 gene editing can / we need to, delete / remove / inactivate, HD / mutant, allele / DNA ; 4 ref. (surplus CAG) repeats / triplets / stutter ;

Write your answer and get it marked

On Oracle Prep you can write or photograph your own answer and have it marked by AI against this mark scheme, with feedback on what you missed.

Sign up free →

About this question

Topic
Genetic technology, A-Level Biology (syllabus 9700). Structured question, 13 marks.
Source
A-Level Biology, Oct/Nov 2022 Paper 4 Variant 1, question 4.

Questions and mark schemes are from past examination papers and remain the copyright of the exam board. How Oracle Prep builds its content

Related Biology questions

© 2026 Oracle Prep